Contact Person
Helen Pettersson

Senior Project Manager
Phone: (M) +45 2337 0040


A mix of key note speaker presentations, shorter presentations and ample network opportunities will fill up the program with the mission to create a platform for industry and academy to meet and initiate new relationships and collaborations.

Program outline

October 4th  
19.00 – 21.00 Speakers and sponsors executive dinner
Crowne Plaza Copenhagen Towers, Ørestad, Copenhagen S.
19.00 Registration & Networking
Drinks and starter
19.25 Welcome
Petter Hartman, CEO, Medicon Valley Alliance
19.30 Main course
20.30 Networking
Coffee and dessert
 October 5th 1-day MVA Microbiome Summit
 Edvard Thomsens Vej 14, Ørestad, Copenhagen S
 8.00 Registration and networking
 8.30 Welcome
Morten Sommer
, Professor, Technical University of Denmark, Denmark

Session 1: Microbiome & metabolic disease
Key Industry – Novo Nordisk A/S

Keynote speaker:
Fredrik BäckhedProfessor, University of Gothenburg, Sweden
Mechanistic studies of the impact of the gut microbiome on obesity and type 2 diabetes

Short talks:
Marju Orho-MelanderProfessor, Lund University, Sweden

Sandrine ClausAssociate Professor, University of Reading, UK

Philip Dubé, Field Applications Scientist, Taconic, USA

9.45 Coffee break and networking

Session 2: Microbiome & CNS disorders
Key Industry – H. Lundbeck A/S

Niels Plath, Vice President, H. Lundbeck A/S

Keynote speaker:
John F CryanProfessor, University College Cork, Ireland

Short talks:
Frida Fåk Hållenius
Associate Professor, Lund University, Sweden

Grégoire Chevalier Associate Researcher, Institut Pasteur, France
Saskia van HemertSenior Scientist, Winclove Probiotics, The Netherlands
Probiotics to treat depressive symptoms?

 11.15 Session 1 and 2: Interactive discussions with audience
 11.45 Lunch, networking and exhibition

Session 3: Microbiome & GI (including oral microbiome)
Key Industry – Ferring A/S

Keynote speaker:
Lars EngstrandProfessor, Karolinska Institutet, Sweden
Prospective large-scale studies for characterization of the normal gastro-intestinal microbiome

Short talks:
Stefan SchreiberProfessor, University Hospital Schleswig-Holstein, Germany

William WadeProfessor, Queen Mary University of London, UK
Probiotics for oral diseases?

Shahram LavasaniFounder and CEO, ImmuneBiotech AB
Designed microbiome therapies targeting the microbes and beyond


Session 4: Microbiome, probiotics & nutrition
Key Industry – Probi AB

Keynote speaker:
Peter TurnbaughAssistant professor, University of California, USA

Short talks:
Åsa HåkanssonAssociate Senior Lecturer, Lund University, Sweden

Karen ScottSenior Research Fellow, University of Aberdeen, UK

Anita WichmannResearch Scientist, Chr. Hansen A/S
The relevance of mode-of-action research on current probiotics in the microbiome era
– The case for Lactobacillus rhamnosus LGG

 14.45 Coffee break and networking
 15.15 Session 3 and 4: Interactive discussions with audience

Session 5: Microbiome & new technique platforms
Key organisation – DTU

Morten Sommer, Professor, Technical University of Denmark, Denmark

Keynote speaker:
Henrik Bjørn NielsenAssociate Professor, Technical University of Denmark
CSO Clinical-Microbiomics, Denmark

Short talks:
Gianni PanagiotouAssociate Professor, Leibniz Institute for Natural Product Research and Infection Biology,
Hans Knoell Institute, Germany
Resistant Starch as a Therapeutic Approach of Obesity in Humans: Towards a Mechanistic Understanding of Gut Microbiome Alterations and Host’s Metabolic Responses

Morten Sommer, Professor, Technical University of Denmark, Denmark
Using cultivation to mine microbiomes? 
Gemma HendersonSenior Scientist, Chr. Hansen A/S
Mining human gut microbial strain collections for next generation probiotics

  Wrap up, reception and networking